naloxone hydrochloride
Generic: naloxone hydrochloride
Labeler: somerset therapeutics, llcDrug Facts
Product Profile
Brand Name
naloxone hydrochloride
Generic Name
naloxone hydrochloride
Labeler
somerset therapeutics, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
naloxone hydrochloride .4 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
70069-072
Product ID
70069-072_7a544942-0f60-4ed3-91df-049b7f74812e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207634
Listing Expiration
2026-12-31
Marketing Start
2017-07-26
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70069072
Hyphenated Format
70069-072
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naloxone hydrochloride (source: ndc)
Generic Name
naloxone hydrochloride (source: ndc)
Application Number
ANDA207634 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .4 mg/mL
Packaging
- 10 CARTON in 1 BOX (70069-072-10) / 1 VIAL, GLASS in 1 CARTON (70069-072-01) / 10 mL in 1 VIAL, GLASS
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "7a544942-0f60-4ed3-91df-049b7f74812e", "openfda": {"upc": ["0370069072011"], "unii": ["F850569PQR"], "rxcui": ["1191222"], "spl_set_id": ["b59ee3cc-9604-4abc-81be-897e2f42aa67"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 CARTON in 1 BOX (70069-072-10) / 1 VIAL, GLASS in 1 CARTON (70069-072-01) / 10 mL in 1 VIAL, GLASS", "package_ndc": "70069-072-10", "marketing_start_date": "20170726"}], "brand_name": "Naloxone Hydrochloride", "product_id": "70069-072_7a544942-0f60-4ed3-91df-049b7f74812e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "70069-072", "generic_name": "Naloxone Hydrochloride", "labeler_name": "Somerset Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naloxone Hydrochloride", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA207634", "marketing_category": "ANDA", "marketing_start_date": "20170726", "listing_expiration_date": "20261231"}